Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice

CompletedOBSERVATIONAL
Enrollment

2,289

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

August 31, 2013

Conditions
Erectile Dysfunction
Interventions
DRUG

Vardenafil (Levitra, BAY38-9456)

Patients with diagnosis of erectile dysfunction and metabolic syndrome who get vardenafil in routine treatment as prescribed by physician

Trial Locations (10)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY